SE407937B - Forfarande for framstellning av 1,3,4-substituerade 2-pyrrolidoner med terapentiska egenskaper - Google Patents

Forfarande for framstellning av 1,3,4-substituerade 2-pyrrolidoner med terapentiska egenskaper

Info

Publication number
SE407937B
SE407937B SE7512354A SE7512354A SE407937B SE 407937 B SE407937 B SE 407937B SE 7512354 A SE7512354 A SE 7512354A SE 7512354 A SE7512354 A SE 7512354A SE 407937 B SE407937 B SE 407937B
Authority
SE
Sweden
Prior art keywords
therapentic
pyrrolidones
substituted
procedure
properties
Prior art date
Application number
SE7512354A
Other languages
English (en)
Swedish (sv)
Other versions
SE7512354L (sv
Inventor
K Kuhlein
D-B Reuschling
M Babej
W Bartmann
G Beck
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19742452536 external-priority patent/DE2452536A1/de
Priority claimed from DE19752528036 external-priority patent/DE2528036A1/de
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of SE7512354L publication Critical patent/SE7512354L/xx
Publication of SE407937B publication Critical patent/SE407937B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2732-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE7512354A 1974-11-06 1975-11-04 Forfarande for framstellning av 1,3,4-substituerade 2-pyrrolidoner med terapentiska egenskaper SE407937B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19742452536 DE2452536A1 (de) 1974-11-06 1974-11-06 Pyrrolidone und verfahren zu ihrer herstellung
DE19752528036 DE2528036A1 (de) 1975-06-24 1975-06-24 Verfahren zur herstellung von pyrrolidonen

Publications (2)

Publication Number Publication Date
SE7512354L SE7512354L (sv) 1976-05-07
SE407937B true SE407937B (sv) 1979-04-30

Family

ID=25767928

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7512354A SE407937B (sv) 1974-11-06 1975-11-04 Forfarande for framstellning av 1,3,4-substituerade 2-pyrrolidoner med terapentiska egenskaper

Country Status (14)

Country Link
US (1) US4071530A (xx)
JP (1) JPS5188960A (xx)
AU (1) AU8629675A (xx)
DK (1) DK496775A (xx)
ES (1) ES442233A1 (xx)
FR (1) FR2290199A1 (xx)
GB (1) GB1514278A (xx)
HU (1) HU173740B (xx)
IE (1) IE41876B1 (xx)
IL (1) IL48408A0 (xx)
IT (1) IT1048822B (xx)
LU (1) LU73711A1 (xx)
NL (1) NL7512794A (xx)
SE (1) SE407937B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4119637A (en) * 1975-09-23 1978-10-10 A. H. Robins Company, Inc. 4-Hydroxymethyl-2-pyrrolidinones
WO2007005176A1 (en) * 2005-06-29 2007-01-11 Allergan, Inc. Pyrrolidinones for the treatment of glaucoma and ocular hypertension
FR2939315B1 (fr) 2008-12-08 2011-01-21 Oreal Composition cosmetique contenant un derive de dibenzoylmethane et un compose ester de 2-pyrrolidinone 4-carboxy ; procede de photostabilisation du derive de dibenzoylmethane
FR2939310B1 (fr) 2008-12-08 2012-04-20 Oreal Compositions cosmetiques comprenant un derive ester de 2-pyrrolidinone 4-carboxy et un filtre lipophile triazine ; utilisation dudit derive comme solvant d'un filtre lipophile triazine
FR2939309B1 (fr) 2008-12-08 2010-12-17 Oreal Utilisation d'un derive ester de 2-pyrrolidinone 4-carboxy comme solvant dans les compositions cosmetiques ; compositions cosmetiques les contenant
FR2961093A1 (fr) 2010-06-09 2011-12-16 Oreal Composition cosmetique comprenant un polymere et un derive de 4-carboxy 2-pyrrolidinone, procede de traitement cosmetique et compose
FR2961101B1 (fr) 2010-06-09 2013-01-25 Oreal Composition comprenant au moins une 2-pyrrolidone fonctionnalisee par un radical ester ou amide, et au moins un pigment ou un colorant direct pour la teinture des matieres keratiniques
FR2977153B1 (fr) 2011-06-29 2013-08-02 Oreal Composition cosmetique comprenant une huile fonctionnalisee et un solvant et procede de traitement cosmetique
WO2013010590A1 (en) 2011-07-21 2013-01-24 L'oreal Cosmetic and/or dermatological composition containing a merocyanine derivative comprising specific polar groups consisting of hydroxyl- and ether-functionalities
DE102012017739A1 (de) 2012-09-07 2014-03-13 Clariant International Ltd. Verfahren zur Herstellung von N-substituierten Pyrrolidoncarbonsäureestern

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2258376A1 (en) * 1974-01-21 1975-08-18 Aries Robert 10-Aza prostaglandins - for treatment of blood pressure and gastro-intestinal disorders and in prepn for confinement

Also Published As

Publication number Publication date
GB1514278A (en) 1978-06-14
IE41876L (en) 1976-05-06
FR2290199A1 (fr) 1976-06-04
US4071530A (en) 1978-01-31
HU173740B (hu) 1979-08-28
IT1048822B (it) 1980-12-20
ES442233A1 (es) 1977-07-01
SE7512354L (sv) 1976-05-07
AU8629675A (en) 1977-05-12
NL7512794A (nl) 1976-05-10
IL48408A0 (en) 1976-01-30
DK496775A (da) 1976-05-07
FR2290199B1 (xx) 1978-07-28
LU73711A1 (xx) 1976-09-06
JPS5188960A (xx) 1976-08-04
IE41876B1 (en) 1980-04-09

Similar Documents

Publication Publication Date Title
DK397575A (da) Fremgangsmade til fremstilling af 1,3,4-trisubstituerede 4-arylpiperidiner
SE7513085L (sv) Forfarande for framstellning av etrar
SE425733B (sv) Forfarande for framstellning av vissa angivna triglyucerider med antiinflammatoriska egenskaper
SE7604475L (sv) Forfarande for framstellning av 1,1,1-triaryl-alkylaminer
SE407937B (sv) Forfarande for framstellning av 1,3,4-substituerade 2-pyrrolidoner med terapentiska egenskaper
SE409452B (sv) Forfarande for framstellning av stilbenderivat
SE7506237L (sv) Forfarande for framstellning av dekahydroisokinolinderivat
SE423813B (sv) Forfarande for framstellning av 1,5-disubstituerade pyrrolidoner med terapeutiska egenskaper
SE7513753L (sv) Forfarande for framstellning av 8,8-disubstituerade-6-metylergoliner och derivat derav
SE413407B (sv) Forfarande for framstellning av n?726-substituerade adeniner
SE403477B (sv) Forfarande for famstellning av substituerade indoleniner
SE411453B (sv) Forfarande for framstellning av 3-fluorcefalosporiner
SE428015B (sv) Forfarande for framstellning av 3.4-dihydrokarbostyrilderivat
DK153479C (da) Analogifremgangsmaade til fremstilling af 1,4-benzodiazepin-2-on-derivater
SE431451B (sv) Forfarande for framstellning av 2,3-dihydroxipropoxikinoliner eller -isokinoliner
SE415763B (sv) Forfarande for framstellning av 1,3-ditiolanyl(2)-och 1,3-ditianyl(2)-foreningar med koronardilaterande egenskaper
SE428922B (sv) Forfarande for framstellning av 13, 14-dihydro-11-dioxi-prostaglandiner
SE7513739L (sv) Forfarande for framstellning av 2-scyl-4-oxo-pyrazino-isokonolin-derivat
SE7601605L (sv) Forfarande for framstellning av 1 alfa,25-dihydroxi-cholkalciferol
SE388854B (sv) Forfarande for framstellning av fenylpyridylaminderivat
SE7506196L (sv) Forfarande for framstellning av amidin-hydrazon-derivat
SE7511801L (sv) Forfarande for framstellning av ympsampolymerisat
SE7512422L (sv) Forfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner
NO139684C (no) Fremgangsmaate for fremstilling av n,n-diallyldikloracetamid
SE7608453L (sv) Forfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner